Atacand Hct NDC 62559-650

NDC codes

FDA NDC Directory

Product NDC (as listed)62559-650Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62559-0650Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62559-650-90	62559065090	90 TABLET in 1 BOTTLE (62559-650-90)Marketed from Oct 1, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Atacand Hct
Generic name (nonproprietary): candesartan cilexetil and hydrochlorothiazide
Active ingredients: Candesartan cilexetil — 16 mg/1Hydrochlorothiazide — 12.5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: ANI Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 021093
Marketing start: Oct 1, 2018
Listing expires: Dec 31, 2026
Other FDA classes: Angiotensin 2 Receptor Antagonists (Mechanism)Increased Diuresis (Physiologic effect)Thiazides (Chemical structure)
Identifiers: Product ID 62559-650_512f014c-894d-43ff-96a6-1ff05bc476e6SPL ID 512f014c-894d-43ff-96a6-1ff05bc476e6SPL set ID d91152c4-66ba-466f-b4f9-0da628d42b1dRxCUI 578325, 578330, 802749, 805855, 805859, 805863UNII 0J48LPH2TH, R85M2X0D68UPC 0362559652902, 0362559651905, 0362559650908
Pharmacologic class: Angiotensin 2 Receptor Blocker; Thiazide Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462559065090 followed by a unit qualifier and the quantity

Package 62559-0650-90. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 22, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE ATACAND HCT is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with ATACAND HCT. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation,…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 021093

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 021093
Product	Strength	Form · route	Labeler	Product NDC
Atacand Hctcandesartan cilexetil and hydrochlorothiazide	Candesartan cilexetil 32 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	ANI Pharmaceuticals, Inc.	62559-651
Atacand Hctcandesartan cilexetil and hydrochlorothiazide	Candesartan cilexetil 32 mg/1; Hydrochlorothiazide 25 mg/1	TabletOral	ANI Pharmaceuticals, Inc.	62559-652
Candesartan Cilexetil and Hydrochlorothiazide	Candesartan cilexetil 16 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	ANI Pharmaceuticals, Inc.	62559-660
Candesartan Cilexetil and Hydrochlorothiazide	Candesartan cilexetil 32 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	ANI Pharmaceuticals, Inc.	62559-661
Candesartan Cilexetil and Hydrochlorothiazide	Candesartan cilexetil 32 mg/1; Hydrochlorothiazide 25 mg/1	TabletOral	ANI Pharmaceuticals, Inc.	62559-662